Enzyme Replacement and Fabry Disease Olive Branch MS

New research suggests that enzyme replacement therapy can make a major difference in the lives of people with Fabry disease, a rare illness that affects the kidneys, heart and brain. The progressive disease, linked to the lack of an enzyme that helps metabolic pathways function in the body, can be fatal because it boosts the risk for a stroke, heart attack and kidney disease.

Nicholas Economides
(901) 521-6217
6911 Parkwood Drive
Olive Branch, MS
Specialties
Cosmetic Surgery
Insurance
Medicare Accepted: No
Workmens Comp Accepted: No
Accepts Uninsured Patients: No
Emergency Care: No


Data Provided by:
Neumon Goshorn
(901) 756-3838
7705 Poplar Avenue
Germantown, TN
Specialties
Cosmetic Surgery
Insurance
Medicare Accepted: No
Workmens Comp Accepted: No
Accepts Uninsured Patients: No
Emergency Care: No


Data Provided by:
Robert Wallace
(901) 347-8290
7945 Wolf River Blvd
Germantown, TN
Specialties
Cosmetic Surgery
Insurance
Medicare Accepted: No
Workmens Comp Accepted: No
Accepts Uninsured Patients: No
Emergency Care: No


Data Provided by:
HealthSource of Southaven
(901) 409-3896
5740 Getwell Road
Southaven, MS

Data Provided by:
Kelsey Canine Medical Center
(901) 861-2275
875 W Poplar
Collierville, TN

Data Provided by:
Nabeel Kahn, MD
(662) 280-8222
9140 Hwy 51 N
Southaven, MS
Business
Delta Gastroenterology & Endoscopy Center PC
Specialties
Gastroenterology

Data Provided by:
Jones Eye Care
(901) 754-2020
2075 Exeter Rd
Germantown, TN

Data Provided by:
Allen K. Raich DPM
(901) 432-1408
920 Estate Dr
Memphis, TN

Data Provided by:
East Memphis Chiropractic
(901) 202-9216
4954 William Arnold Rd
Memphis, TN

Data Provided by:
Allen K. Raich DPM
(901) 471-6538
1121 Poplar View Ln
Collierville, TN

Data Provided by:
Data Provided by:

Enzyme Replacement and Fabry Disease

Provided By:

WEDNESDAY, Dec. 2 (HealthDay News) -- New research suggests that enzyme replacement therapy can make a major difference in the lives of people with Fabry disease, a rare illness that affects the kidneys, heart and brain.

The progressive disease, linked to the lack of an enzyme that helps metabolic pathways function in the body, can be fatal because it boosts the risk for a stroke, heart attack and kidney disease.

A study published Dec. 1 in The Lancet analyzed a treatment that replaced an enzyme called agalsidase alfa.

The researchers found that the treatment reduced signs of heart disease in people who had oversized hearts. It also appeared to improve kidney function, lower pain levels and improve scores on quality-of-life surveys.

"Enzyme-replacement therapy has only been available typically since 2001, and, thus, duration of exposure might be too short to assess whether this strategy prolongs life," the researchers wrote in an accompanying commentary. Whether the treatment, which they described as costly, helps people live longer needs confirmation, they noted.

More information

The U.S. National Institute of Neurological Disorders and Stroke has more on Fabry disease.

SOURCE: The Lancet, news release, Dec. 1, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

© 1996-2010

Contemporary Media
460 Tennessee Street, 2nd Floor | Memphis, TN 38103
Visit our other sites: Memphis Magazine | Memphis Parent | Memphis Business Quarterly
Powered by Foundation